What is Zacks Research’s Estimate for Teleflex Q2 Earnings?

Teleflex Incorporated (NYSE:TFX) – Equities research analysts at Zacks Research cut their Q2 2025 EPS estimates for Teleflex in a note issued to investors on Tuesday, June 24th. Zacks Research analyst R. Department now expects that the medical technology company will post earnings of $3.34 per share for the quarter, down from their prior estimate of $3.35. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q3 2025 earnings at $3.36 EPS, Q4 2025 earnings at $3.72 EPS, FY2025 earnings at $13.33 EPS, Q3 2026 earnings at $3.78 EPS, Q4 2026 earnings at $3.51 EPS and FY2026 earnings at $13.74 EPS.

TFX has been the topic of a number of other reports. Royal Bank Of Canada reduced their price target on shares of Teleflex from $150.00 to $145.00 and set a “sector perform” rating on the stock in a research report on Friday, May 2nd. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Raymond James Financial cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Finally, Morgan Stanley reduced their price target on shares of Teleflex from $191.00 to $173.00 and set an “overweight” rating on the stock in a research report on Monday, May 5th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $164.63.

Teleflex Trading Down 0.7%

Shares of TFX stock opened at $119.29 on Thursday. The stock has a market cap of $5.27 billion, a price-to-earnings ratio of 37.63, a price-to-earnings-growth ratio of 1.88 and a beta of 1.10. The company has a quick ratio of 1.32, a current ratio of 2.28 and a debt-to-equity ratio of 0.44. Teleflex has a fifty-two week low of $115.94 and a fifty-two week high of $249.91. The firm’s 50 day moving average price is $124.81 and its two-hundred day moving average price is $148.76.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. Teleflex’s revenue was down 5.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.21 earnings per share.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TFX. Norges Bank acquired a new position in shares of Teleflex during the fourth quarter worth $100,328,000. Dimensional Fund Advisors LP lifted its position in shares of Teleflex by 69.5% during the first quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock worth $119,927,000 after purchasing an additional 355,720 shares in the last quarter. Invesco Ltd. raised its holdings in Teleflex by 48.1% in the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock valued at $190,188,000 after acquiring an additional 347,003 shares in the last quarter. Diamond Hill Capital Management Inc. raised its holdings in Teleflex by 122.8% in the first quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company’s stock valued at $80,784,000 after acquiring an additional 322,222 shares in the last quarter. Finally, Invenomic Capital Management LP raised its holdings in Teleflex by 1,400.1% in the first quarter. Invenomic Capital Management LP now owns 344,732 shares of the medical technology company’s stock valued at $47,639,000 after acquiring an additional 321,751 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were given a dividend of $0.34 per share. The ex-dividend date was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.14%. Teleflex’s payout ratio is currently 42.90%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.